ZA934883B - Composition for curing sjoegren syndrome disease - Google Patents

Composition for curing sjoegren syndrome disease

Info

Publication number
ZA934883B
ZA934883B ZA934883A ZA934883A ZA934883B ZA 934883 B ZA934883 B ZA 934883B ZA 934883 A ZA934883 A ZA 934883A ZA 934883 A ZA934883 A ZA 934883A ZA 934883 B ZA934883 B ZA 934883B
Authority
ZA
South Africa
Prior art keywords
composition
curing
syndrome disease
sjoegren syndrome
quinuclidine
Prior art date
Application number
ZA934883A
Other languages
English (en)
Inventor
Nobuaki Abe
Yasuyoshi Takeshita
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16540522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA934883(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of ZA934883B publication Critical patent/ZA934883B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA934883A 1992-07-10 1993-07-07 Composition for curing sjoegren syndrome disease ZA934883B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4207485A JP2683783B2 (ja) 1992-07-10 1992-07-10 シェーグレン症候群治療剤

Publications (1)

Publication Number Publication Date
ZA934883B true ZA934883B (en) 1994-02-03

Family

ID=16540522

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934883A ZA934883B (en) 1992-07-10 1993-07-07 Composition for curing sjoegren syndrome disease

Country Status (15)

Country Link
US (1) US5340821A (da)
EP (1) EP0578511B1 (da)
JP (1) JP2683783B2 (da)
KR (1) KR100331046B1 (da)
AT (1) ATE184483T1 (da)
AU (1) AU666734B2 (da)
CA (1) CA2099970C (da)
DE (1) DE69326395T2 (da)
DK (1) DK0578511T3 (da)
ES (1) ES2138613T3 (da)
IL (1) IL106218A (da)
NO (1) NO303765B1 (da)
NZ (1) NZ248099A (da)
TW (1) TW230750B (da)
ZA (1) ZA934883B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2852608B2 (ja) * 1994-06-27 1999-02-03 雪印乳業株式会社 口腔乾燥症治療剤
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
JP4447685B2 (ja) * 1999-01-14 2010-04-07 第一三共株式会社 皮膚乾燥症治療剤
US20110150974A1 (en) * 2004-08-06 2011-06-23 Daiichi Pharmaceutical Co., Ltd. Agent For Oral Mucosal Administration
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
ZA200702784B (en) * 2004-10-05 2008-09-25 Astellas Pharma Inc Pharmaceutical composition for treatment of tear and salivary fluid drying
EP2275096A3 (en) * 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8143400B2 (en) * 2008-01-10 2012-03-27 Apotex Pharmachem Inc. Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
ES2443847T3 (es) 2009-11-12 2014-02-20 Acacia Pharma Limited Uso de betanecol para el tratamiento de xerostomía
GB201107533D0 (en) 2011-05-06 2011-06-22 Acacia Pharma Ltd Formulaiton
CN102846607A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以盐酸西维美林为活性成分的固体制剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001396A (en) * 1971-08-04 1977-01-04 Chinoin Pharmaceutical And Chemical Works Ltd. Hormonal product extracted from parathyroid gland and process for the preparation thereof
US4110441A (en) * 1974-04-29 1978-08-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Gamma-l-glutamyl cholamine phosphate
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
ZA868369B (en) * 1986-01-10 1987-11-25 Israel State Derivatives of quinuclidine
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5242930A (en) * 1991-02-11 1993-09-07 Merck Sharp & Dohme Ltd. Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy

Also Published As

Publication number Publication date
DE69326395D1 (de) 1999-10-21
US5340821A (en) 1994-08-23
NO932520L (no) 1994-01-11
ES2138613T3 (es) 2000-01-16
JPH0624981A (ja) 1994-02-01
IL106218A0 (en) 1993-11-15
KR100331046B1 (ko) 2002-08-19
ATE184483T1 (de) 1999-10-15
JP2683783B2 (ja) 1997-12-03
TW230750B (da) 1994-09-21
EP0578511A1 (en) 1994-01-12
IL106218A (en) 1997-02-18
EP0578511B1 (en) 1999-09-15
NZ248099A (en) 1999-07-29
AU4181993A (en) 1994-01-13
AU666734B2 (en) 1996-02-22
CA2099970C (en) 2003-12-30
NO303765B1 (no) 1998-08-31
NO932520D0 (no) 1993-07-09
KR940005274A (ko) 1994-03-21
DE69326395T2 (de) 2000-04-20
CA2099970A1 (en) 1994-01-11
DK0578511T3 (da) 2000-04-03

Similar Documents

Publication Publication Date Title
ZA934883B (en) Composition for curing sjoegren syndrome disease
ATE117685T1 (de) Chinoloncarbonsäure-derivate.
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
ZA888186B (en) Quinolinecarboxylic acid derivatives
HK1030413A1 (en) Aryloxyaniline derivatives
TW206970B (da)
NO982873D0 (no) 1-metylkarbapenemderivater
DE68913835D1 (de) N-substituierte Amid-Derivate.
AU6063398A (en) Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
AU6063298A (en) Benzamide derivative, anti-ulcer drug, and antibacterial drug
HU9600621D0 (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
AU1639197A (en) Pyridine derivative, anti-ulcer drug, and antibacterial drug
EP0555479A4 (da)
AU655869B2 (en) An amphoteric tricyclic compound
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
AU1855088A (en) Treating agent for heart failure
HU9601701D0 (en) Aromatic hydroxamic acid compounds, process for producing them and their use
AU3932297A (en) N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug
EP0782857A4 (en) THERAPEUTIC AND PROPHYLACTIC DRUG OF NERVOUS SYSTEM DISORDERS
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
EP0717990A4 (en) PREPARATION FOR TREATING DRUG ADDICTION